Athersys partnered with the National Multiple Sclerosis Society's Fast Forward LLC to develop Athersys' MultiStem to treat multiple sclerosis (MS)

Athersys Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$32.7m on 10/21/2011 [market cap]

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

National Multiple Sclerosis Society

U.S. / Non-Profit or Major Disease Foundation

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced